In MAESTRO project, novel technologies in patient alignment, organ tracking, dose calculation and dose measurement will be developed, together with advanced software for radiotherapy image processing and merging for therapy planning using new conformal therapy modalities are investigated. Clinical environments will be provided for pre-clinical validation.

Methods and advanced Equipment for Simulation and Treatment in Radiation Oncology: programa MAESTRO / G.Biti; M.Bucciolini; L.Livi; F.Paiar;S.Pallotta; C.Talamonti. - In: ONCOLOGIA. - ISSN 0378-4835. - STAMPA. - 27:(2004), pp. 30-31. (Intervento presentato al convegno 3ª Jornadas Oncológicas Internacionales "La oncología radioterápica en el tercer milenio" tenutosi a Madrid, Spagna nel 17-19/06/2004) [10.4321/S0378-48352004000600004].

Methods and advanced Equipment for Simulation and Treatment in Radiation Oncology: programa MAESTRO

BITI, GIAMPAOLO;BUCCIOLINI, MARTA;LIVI, LORENZO;PALLOTTA, STEFANIA;TALAMONTI, CINZIA
2004

Abstract

In MAESTRO project, novel technologies in patient alignment, organ tracking, dose calculation and dose measurement will be developed, together with advanced software for radiotherapy image processing and merging for therapy planning using new conformal therapy modalities are investigated. Clinical environments will be provided for pre-clinical validation.
2004
oncologia
3ª Jornadas Oncológicas Internacionales "La oncología radioterápica en el tercer milenio"
Madrid, Spagna
17-19/06/2004
G.Biti; M.Bucciolini; L.Livi; F.Paiar;S.Pallotta; C.Talamonti
File in questo prodotto:
File Dimensione Formato  
biti maestro.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 73.09 kB
Formato Adobe PDF
73.09 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/346565
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact